a program can help seniors and still have a structural payment problem. that is the tension the industry keeps trying to flatten.
Prompted by a Penn Leonard Davis Institute discussion featuring Cheryl L. Damberg, PhD, MPH, Director of the RAND Center of Excellence on Health System Performance, Distinguished Chair in Health Care Payment Policy, and Principal Senior Economist at RAND; Rachel M. Werner, MD, PhD, Executive Director of the Leonard Davis Institute of Health Economics, Professor of Medicine at the University of Pennsylvania Perelman School of Medicine, and Robert D. Eilers Memorial-William Maul Measey Professor in Health Care Management and Economics at the Wharton School; and Sachin H. Jain, MD, MBA, CEO of SCAN Group and SCAN Health Plan, this piece takes the broader question they surfaced and pushes it into a more practical frame. Reference: Penn LDI event page.
Medicare Advantage gets debated like a courtroom case.
One side argues that the program costs the government more than it was supposed to. The other points to the member experience and says seniors are getting lower premiums, more predictable cost sharing, and benefits that traditional Medicare still leaves exposed. Both arguments have truth in them. That is exactly why the debate never gets settled.
The cleaner way to look at it is this.
Medicare Advantage is being asked to do two different jobs at once.
One job is public finance. Can private plans deliver Medicare more efficiently and lower the government’s cost?
The other job is practical coverage. Can a senior on a fixed income get a package that feels affordable, usable, and protective in real life?
Those are not the same test.
And once you separate them, the whole conversation gets easier to understand.
From the member’s seat, Medicare Advantage has obvious pull. Lower visible monthly cost. An out-of-pocket maximum. Extra benefits that feel relevant to day-to-day life. Dental. Vision. Transportation. Over-the-counter support. Food-related benefits. A simpler shopping story. For many seniors, especially lower-income seniors, that package feels more reachable than trying to stitch together traditional Medicare, a Part D plan, and a Medicare Supplement policy. That appeal is real. It is not an illusion invented by marketing.
At the same time, market behavior does not come from appeal alone.
It comes from incentives, packaging, and distribution.
A product grows faster when it is easier to explain, easier to promote, and easier to sell. Medicare Advantage has all three. It is a cleaner front-end offer. It gives marketers more to talk about. It gives distributors more to work with. It gives seniors a more visible answer to the question, “What do I get for what I pay?” Traditional Medicare often enters that conversation later, and sometimes only as a technical alternative instead of a serious consumer choice. The transcript makes that tension plain. People aging into Medicare often do not fully understand the tradeoffs, while the market around them is very ready to sell the richer-looking option.
That is where this stops being a policy debate and becomes an operating one.
What behavior does the current setup reward?
Right now, it rewards front-end attractiveness very well. It rewards visible benefit richness. It rewards growth. It can reward quality, but not always cleanly. It can also reward coding intensity and payment mechanics that are much harder for the public to see.
That last part matters.
A lot of the generosity people associate with Medicare Advantage is being financed through a system of benchmarks, bids, rebates, quality bonuses, and risk-adjusted payments. Those mechanisms help plans buy down premiums, lower cost sharing, and fund supplemental benefits. They also create the possibility that the government is paying more than it should for those outcomes. The transcript goes straight at that point, with explicit concern that the program has not delivered the government savings it originally promised and that payment levels have remained above fee-for-service benchmarks in important ways.
That is why the standard talking points feel incomplete.
Saying “look at all the benefits” misses the financing question.
Saying “look at the overpayments” misses the member reality.
Both are part of the same story.
Supplemental benefits are probably the best example. They are one of the strongest reasons seniors like Medicare Advantage. They also expose one of the program’s most uncomfortable gaps. A benefit can exist on paper and still be weak in practice. It can be real enough for a brochure and hard enough to use that the member never feels the value. The discussion raised exactly that concern. Some benefits are structured around low expected utilization. Some are hard to activate. Some look generous until the member tries to use them in the real world.
That should force a shift in how the industry talks about value.
A benefit is not meaningful because it appears in a plan grid.
It is meaningful when a member can understand it, access it, and use it without absurd friction.
Healthcare keeps making the same mistake here. It confuses available with accessible. The member does not experience value through benefit design language. The member experiences value through use. Can they find the dentist? Can they use the transportation benefit when they need it? Can they activate the service without getting lost in process? Can they stay with the providers they already trust? Those are not side questions. They are the questions.
The same problem shows up in star ratings.
Star ratings have pushed plans to care more about quality measures, customer experience, and performance discipline than traditional fee-for-service Medicare has historically pushed on its own. That part should be acknowledged. But once a scoring system carries major payment consequences, behavior starts clustering around the score. Plans have reason to pursue the metrics, shape the population mix, and protect the economics that come with higher ratings. The transcript captures that tension clearly. Star ratings matter. They also distort. And if the differences between ratings are not meaningfully tied to better member experience or better care, the payment consequences start looking too generous for the signal they are based on.
When a metric becomes the goal, it gets gamed.
That line is not cynicism. It is one of the oldest operating truths in healthcare.
Risk adjustment may be the clearest case of all.
In theory, risk adjustment exists for a good reason. Plans taking care of sicker populations should be paid more fairly. Without that, the market would avoid complexity. But the same mechanism can drift into a revenue strategy when coding sophistication starts outperforming actual care improvement. That is one of the sharpest warnings embedded in the discussion. Too much of the last decade’s so-called progress in value-based care may have had less to do with better care delivery and more to do with getting better at capturing revenue signals.
That is a serious problem because it changes what operators chase.
If financial lift comes more easily from coding intensity than from reducing avoidable admissions, improving chronic care management, or moving seniors into better sites of care, the system will produce more coding behavior. That does not mean every plan or provider group is acting in bad faith. It means the rails matter. A system that tolerates drift will get drift. A system that rewards aggressive documentation more than actual improvement will get more documentation theater.
Still, the answer cannot be to swing blindly in the other direction.
Tightening payments too hard or too fast creates real disruption for members. Benefits get cut. Plans exit counties. Networks get tighter. Seniors end up with less stability and more confusion. The challenge is not to strip the program down until it fails the people currently relying on it. The challenge is to keep the parts that are helping members while putting more pressure on the parts that distort cost, competition, and trust.
That is where the conversation should go.
Toward benefit usability, not just benefit count.
Toward member understanding, not just enrollment growth.
Toward cleaner star rating logic, where quality differences actually mean something.
Toward tighter risk adjustment oversight, where the market can still serve sicker populations without turning documentation into a parallel business model.
Toward a more honest comparison between Medicare Advantage and traditional Medicare, where policymakers stop pretending one side of the program can carry all the innovation while the other stands still.
My own take is straightforward.
Medicare Advantage is working for many seniors in the way that matters most to them right now. It makes coverage feel more affordable. It gives more visible protection against out-of-pocket shock. It offers benefits traditional Medicare still leaves exposed. That should be taken seriously.
At the same time, the system around it still looks too comfortable with payment distortion, coding-driven advantage, and benefit designs that can sound better than they perform. That should be taken seriously too.
So the real question is not whether Medicare Advantage “works” in some broad ideological sense.
The real question is whether the program can keep delivering member value while getting more disciplined about how that value is financed, measured, explained, and enforced.
That is a better test.
It asks whether the benefit is usable, not just marketable.
Whether the payment is fair, not just tolerated.
Whether growth reflects fit, not just distribution power.
Whether quality signals are real, not just lucrative.
And whether seniors are choosing with enough clarity to know what they are actually buying.
That is where this debate gets more honest. And that is where it starts to matter more than the slogans on either side.
